Citius Oncology, Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Citius Oncology, Inc.
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
/ 
Frequently asked questions
To buy Citius Oncology, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Citius Oncology, Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Citius Oncology, Inc. is CTOR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Citius Oncology, Inc. has its primary listing on NASDAQ (Small cap). You can trade Citius Oncology, Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Citius Oncology, Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Citius Oncology, Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Citius Oncology, Inc..